Watch These Marvell Technology Price Levels as Stock Tumbles on Soft Sales Outlook

Marvell Technology (MRVL) shares plunged nearly 17% after the chip designer provided a third-quarter revenue forecast of $2.06 billion (give or take 5%), falling short of Wall Street's estimates. This guidance miss exacerbates existing investor concerns regarding the company's ability to meet high AI-driven growth expectations and the impact of U.S. chip restrictions on its significant China sales, contributing to a year-to-date decline exceeding 40% for the stock and reinforcing a bearish technical outlook.

Analysis

Marvell Technology (MRVL) shares experienced a significant sell-off, plunging nearly 17%, after the company issued third-quarter revenue guidance of $2.06 billion (+/- 5%), which fell short of consensus estimates. This weak forecast amplifies existing market concerns that have contributed to a more than 40% decline in the stock's value year-to-date. The guidance miss is particularly impactful in the context of high investor expectations for artificial intelligence-driven growth, which management commentary suggests may be delayed, with CEO Matthew Murphy projecting flat sequential data center sales for Q3 before an anticipated strengthening in Q4. Furthermore, the share price decline reflects persistent uncertainty surrounding U.S. chip restrictions on China, a market that constitutes a large portion of Marvell's revenue. The technical picture reinforces this bearish sentiment; the stock has broken below its uptrend line from the April low and, more critically, has failed to reclaim its 200-day moving average, indicating that bears maintain control over the longer-term trend.

Key Decisions for Investors

• Investors should monitor the key technical support levels at $62, $56, and $50, as a failure to hold these points could indicate further downward momentum, while a stabilization could offer a tactical entry point.
• Given the flat Q3 data center sales forecast, it is prudent to reassess the timeline for AI-related revenue growth and evaluate if the current stock valuation adequately prices in the execution risk and potential delays.
• The significant revenue exposure to China remains a primary risk factor; therefore, any position in MRVL should account for potential volatility stemming from changes in U.S. chip export control policies.
• While management anticipates a stronger fourth quarter, investors should look for corroborating evidence in subsequent reports or industry data before pricing in a sustained recovery.